Références 1 Center for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases, The Pink Book, 13th Edition april 2015. www.cdc.gov/ vaccines/pubs/pinkbook/index.html. 2 Agentschap zorg en gezondheid. Dossier griepvaccinatie 2014. Antwoorden voor professionelen op vragen over griepvaccinatie. www.griepvaccinatie.be. 3 OMS. Grippe (saisonnière). Aidemémoire n°211, mars 2014. www.who.int/mediacentre/ factsheets/fs211/fr/ 4 Wetenschappelijk instituut volksgezondheid (WIV). Virological Surveillance of Influenza in Belgium. Season 2013-2014. 5 European centre for disease prevention and control (ECDC). Influenza virus characterisation. Surveillance report. Summary Europe, march 2015. http://ecdc. europa.eu/en/publications/_layouts/ forms/Publication_DispForm. aspx?List=4f55ad51-4aed-4d32- b960-af70113dbb90&ID=1295. 6 EBM guideline Influenza. 5-9-2010. Duodecim Medical publications, consulté via www.ebmpracticenet.be. 7 EBM guideline. Traitement de la grippe - instructions pour le patient, 23-3-2001. Duodecim Medical publications, consulté via www.ebmpracticenet.be. 8 World Health Organization. Questions and Answers. Recommended composition of influenza virus vaccines for use in the northern hemisphere 2015-16 influenza season and development of candidate vaccine viruses for pandemic preparedness. 26/02/2015. 9 Centre fédéral d’expertise des soins de santé. Vaccination contre la grippe saisonnière : priorité aux enfants ou à d’autres groupes cibles ? KCE Report 204As. 2013. https://kce.fgov. be/publication/report/seasonalinfluenza vaccination-prioritizingchildren or-other-target-groupspart#. VaOkNIV9JOI. 10 World Health Organization. Recommended composition of influenza virus vaccines for use in the 2015-2016 northern hemisphere influenza season. 26/02/2015. www.who.int/influenza/vaccines/ virus/recommendations/2015_16_ north/en/. 11 European Medicines Agency (EMA)- Committee for Medicinal Products for Human Use. BWP Ad-hoc Influenza working Group. Amended EU recommendations for the seasonal influenza vaccine composition for the season 2015/2016. 21/05/2015. www.ema.europa.eu/ema/index. jsp?curl=pages/news_and_events/ news/2015/05/news_detail_002339. jsp&mid=WC0b01ac058004d5c1. 12 Ambrose C.S. , Levin M.J. The rationale for quadrivalent influenza vaccines. Human vaccines & immunotherapeutics, january 2012, 8(1) : 81-88. 13 Haut conseil de la santé publique (France). Avis relatif à l’utilisation du vaccin contre la grippe saison saisonnière FluarixTetra®. 23 mai 2014. 14 Centre Belge d’Information Pharmacothérapeutique. Deux vaccins « tétravalents » contre la grippe sont annoncés pour la saison grippale 2015-2016 : un vaccin inactivé (injectable) (Alpharix Tetra®) et un vaccin vivant (par voie nasale) (Fluenz Tetra®). Bon à savoir. 21/05/15. www.cbip.be. Journal de Pharmacie de Belgique - 97ème a 22 nnée n° 3 - septembre 2015 15 McKeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): A review of its use in the prevention of disease caused by Influenza A and B. Drugs (2013) 73 : 1587-1594. 16 Hoge GezondheidsRaad. Advies nr 9211 - Vaccinatie tegen seizoensgebonden griep. Winterseizoen 2014- 2015. 3/09/2014. www.health. belgium.be/internet2Prd/groups/ public/@public/@shc/documents/ ie2divers/19098147.pdf. 17 Centers for Disease Control and Prevention (CDC). Quadrivalent Influenza Vaccine. Questions & Answers. www.cdc.gov/flu/protect/ vaccine/quadrivalent.htm. 18 AstraZeneca. FluenzTMTetra (live attenuated, nasal, influenza vaccine) Scientific dossier Belgium- Luxembourg. 2014. Information provided for educational purposes only. 19 Fleming D.M. et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatric Infectious Disease Journal, oct 2006, 25(10) : 860-869. 20 Belshe R.B. et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med, febr. 2007, 356-7. 21 Ashkenazi S. et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006 oct, 25(10) : 870-9. PratiqueF armaceutisch Tijdschrift voor België
Journal_de_Pharmacie_de_Belgique_n3_ septembre_2015
To see the actual publication please follow the link above